Johnson & Johnson is the world’s most innovative pharmaceutical company
Johnson & Johnson spent £37.1 billion on intangible assets and £11.87 billion on R&D last year
Johnson & Johnson has made it to the...
Elsevier unveiled PharmaPendium: a drug development decision-making platform
The new drug research initiative provides preclinical and clinical data that enable researchers to make informed decisions regarding drug enhancement
The global company in information...